| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |